- English
- 简体中文
- Español
- Português
- русский
- Français
- 日本語
- Deutsch
- tiếng Việt
- Italiano
- Nederlands
- ภาษาไทย
- Polski
- 한국어
- Svenska
- magyar
- Malay
- বাংলা ভাষার
- Dansk
- Suomi
- हिन्दी
- Pilipino
- Türkçe
- Gaeilge
- العربية
- Indonesia
- Norsk
- تمل
- český
- ελληνικά
- український
- Javanese
- فارسی
- தமிழ்
- తెలుగు
- नेपाली
- Burmese
- български
- ລາວ
- Latine
- Қазақша
- Euskal
- Azərbaycan
- Slovenský jazyk
- Македонски
- Lietuvos
- Eesti Keel
- Română
- Slovenski
- मराठी
- Srpski језик
Nintedanib Esylate
Nintedanib Esylate in-domus specification.DMF praesto est.
CAS:656247-18-6
Model:656247-18-6
Mitte Inquisitionem
depictio producti
CAS Numberï¼656247-18-6
Formulae hypotheticaeï¼C31H33N5O4.C2H6O3SM. Pondusï¼649.75706
Notitia generali
Nintedanib Esylate, moleculae tyrosinae kinasi inhibitoris TKI oritur ex novo studio pro curatione IPF.
Receptatores (PDGF α et ), factores receptores fibroblast incrementi endothelialis (FGFR1-3), et vasculares incrementi endothelialis receptatores (VEGFR1-3), certatim ligant ad sitos adenosinos triphosphatos (ATP) ligandos. horum receptorum intercluderent vias significantes processus fibroblast et inhibentes proliferation, metastasis et transformatio fibroblastorum, progressionem IPF morbi retardans.Ordinationes
Nintedanib Esylatehabet in domo speciem. DMF probatus.
Formulae Available
Capsula
Hot Tags: Nintedanib Esylate, China, Suppliers, Manufacturers, Factory
Product Tag
Related Categoria
Mitte Inquisitionem
Libenter placet, ut inquisitionem tuam in forma infra exhibeas. Respondebimus tibi in 24 horis.
